Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack An Overview of Major Trials and Meta-Analyses

THERAPEUTIC CLASS

Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack An Overview of Major Trials and Meta-Analyses

Hackam DG - Personal Name;

Stroke is a leading cause of mortality and disability worldwide. Initial manifestations of acute cerebral ischemia, such as ischemic stroke and transient ischemic attack (TIA), are often followed by recurrent vascular events, including recurrent stroke. To reduce this burden,
antiplatelet therapy is a key component of the management of noncardioembolic ischemic stroke and TIA.

Availability

Location name is not set Location name is not set

REQJ4499-2

Available

Detail Information

Series Title: -
Call Number: -
Publisher: : .,
Collation: -
Language: English
ISBN/ISSN: -
Classification: NONE
Content Type: LITERATURE
Media Type: -
Carrier Type: -
Edition: -
Subject(s): Vaclo
Clotix
Cardiovascular & Hematopoeiteic System
Briclot
Specific Detail Info: Stroke. 2019;50:773-778
Statement of Responsibility: -

Other version/related

No other version available

File Attachment

Read Here

Comments

You must be logged in to post a comment